SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-023198
Filing Date
2018-04-27
Accepted
2018-04-27 16:57:25
Documents
9
Period of Report
2018-06-20
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv491398-def14a.htm DEF 14A 1037088
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_intercept-new.jpg GRAPHIC 34913
4 GRAPHIC sig_mpruzanski.jpg GRAPHIC 14498
5 GRAPHIC spacer.gif GRAPHIC 43
6 GRAPHIC tv491398_chrt-pier.jpg GRAPHIC 54454
7 GRAPHIC tv491398_icocheck.jpg GRAPHIC 3564
8 GRAPHIC tv491398_proxycd1.jpg GRAPHIC 755554
9 GRAPHIC tv491398_proxycd2.jpg GRAPHIC 615971
  Complete submission text file 0001144204-18-023198.txt   3075799
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35668 | Film No.: 18785205
SIC: 2834 Pharmaceutical Preparations